CORAL GABLES, FL / ACCESSWIRE / June 8, 2015 / Oil analysts are starting to lean toward a more favorable outcome for oil prices in relation to a prosperous global economy. With that, markets have continued to progress toward new levels. Just a few weeks ago, the Dow tested18,350+ as stocks headed higher into the thick of the second quarter. This hasn’t been noticed in segments only related to larger cap companies either. Many small cap stocks and micro cap stocks have reacted favorably in the market as well. Enviro-Serv Inc. (EVSV), U.S. Precious Metals (USPR), and RXi Pharmaceuticals Corporation (RXII) have all seen upswings in price and volume over the better part of the last few weeks.
Enviro-Serv has seen the largest increase in price over the last several weeks. What started out as a fairly inactive stock trading around $0.0001, this penny stock has made its way to highs of $0.0015 marking a run of more than 1,000% within the matter of a few short weeks. A series of announcements has garnered more attention as of late. Most recently the Company announced that Enviro-Serv, Inc., through its subsidiary X-Terminate Pest Management, secured its largest single multi-location termite contact in their history. Furthermore, Enviro-Serv also has a current bid for a larger government contract that management is "expecting a decision soon and are optimistic about the outcome."
U.S. Precious Metals has also seen its fair share of recent price and volume increase. A penny stock that was once trading an average of less than 150,000 shares a day, just a few short months ago has now established an average above 200,000 while realizing a price increase by as much as 82% since April lows. Earlier this year, U.S. Precious Metals announced the hiring of ACT HOLDINGS, LLC, to act as operator for the Company's 2015 core drilling program on its mining concessions located in Michoacan, Mexico.
RXi Pharmaceuticals is no stranger to market activity. For the better part of the last 2 weeks, shares of RXII have increased by as much as 31% after hitting lows of $0.342 in May. Last week the Company was granted a Notice of Allowance from the United States Patent and Trademark Office on its self-delivering RNAi platform, sd‑rxRNA(R). The patent, titled "RNA Interference in Ocular Indications," covers methods of use of RXi's VEGF-targeting and CTGF-targeting self-delivering rxRNAs(R), including RXI-109, for use in the eye. "The Company continues to advance its clinical programs as planned and we look forward to providing additional updates on our ophthalmology and dermatology programs in the coming months," stated Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals.
ABOUT US:
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
CONTACT:
Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com
SOURCE: DailyStockReporter.com